title: Long-term survival of stage A prostate carcinoma, atypical hyperplasia/adenosis and BPH.
abstract: Between 1972 and 1986, 134 patients with stage A carcinoma of the prostate (CAP) were diagnosed at a single Veterans Administration medical centre and followed annually by the hospital tumour registry. Seventy-four were classified as stage A1, defined as non-palpable, well-differentiated CAP, regardless of amount, found unexpectedly on transurethral resection of the prostate (TURP). Twenty-eight were classified as stage A2, defined as non-palpable, moderately or poorly differentiated CAP, regardless of amount, found unexpectedly on TURP. The remaining 32 were reclassified as atypical hyperplasia/adenosis (AH/A) rather than CAP. The survival of each group was compared with the survival of a control group from the same medical centre who had TURPs showing histologically proven benign prostatic hyperplasia (BPH). Survival and tumour progression were similar for patients with stage A1 CAP, AH/A and BPH. Furthermore, patients with stage A1 CAP, with or without therapy, had similar survivals as patients with BPH in each age group (under 65, 65-74 and over 74 years). Stage A2 CAP was associated with a significantly worse survival and more tumour progression. Within stage A1 CAP and stage A2 CAP the percentage of chips with CAP or the amount of CAP removed did not affect survival.
authors.affiliation: Department of Pathology, Veterans Administration Medical Center, Ann Arbor, Michigan 48105.
authors.forename: P N
authors.initials: PN
authors.lastname: Brawn
authors.forename: E H
authors.initials: EH
authors.lastname: Johnson
authors.forename: V O
authors.initials: VO
authors.lastname: Speights
authors.forename: M
authors.initials: M
authors.lastname: Riggs
authors.forename: M
authors.initials: M
authors.lastname: Lind
authors.forename: N
authors.initials: N
authors.lastname: Bell
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D016016:Proportional Hazards Models; D011469:Prostatic Diseases / Q000150:complications / Q000401:mortality* / Q000473:pathology; D011470:Prostatic Hyperplasia / Q000150:complications / Q000401:mortality* / Q000473:pathology; D011471:Prostatic Neoplasms / Q000150:complications / Q000401:mortality* / Q000473:pathology; D016019:Survival Analysis; D013997:Time Factors